Received May 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y014436 | — |
No additional AE; The medical assistant is reporting that a patient received improperly stored vaccine; This spontaneous report was received from a Physician Assistant (medical assistant) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, past drug reactions and allergies were not reported. On 21-APR-2025, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA) (PROQUAD), 1 dosage form, administered as prophylaxis (lot number Y014436 has been verified to be valid for Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live [PROQUAD], expiration date 22-FEB-2026; vaccination scheme frequency, anatomical site of injection, and route of administration were not provided), which was reconstituted with sterile diluent (BAXTER STERILE DILUENT) (lot number and expiration date were not provided), after a temperature excursion (TE) at 5.5 degree Fahrenheit (F) up to 14.4 degree F for 40 minutes, and 14.5 degree F up to 46.4 degree F (15.8 degree F) for 10 minutes, with no previous TE (Product storage error). No additional adverse event was reported for the patient.
Sterile diluent